Mylan settlements

Mylan is the subject of a $60,000,000 securities class action settlement covering all persons and entities who purchased or acquired the publicly traded common stock of Mylan N.V. between February 16, 2016 and May 7, 2019. Eligible shareholders may receive approximately $0.11 per share before deductions, subject to a minimum payout threshold of $10. The claim deadline is July 10, 2026, and the official claim form is available through the settlement administrator.

at least $10 potential payment
Free file on the official form

Check what you may be owed Free · takes 20 seconds

Published directory

1 published record

False Advertising

Mylan $60,000,000 Securities Class Action Settlement

Mylan N.V., the pharmaceutical maker, settled a securities class action for $60,000,000 after investors alleged the company manipulated quality-control test data at its Morgantown, West Virginia manufacturing plant to make it look like drugs were passing inspection. The case covered stock purchased between February 16, 2016 and May 7, 2019. The claim deadline passed on July 10, 2026, and the case is now closed.

Claim window closed Evidence-verified

Related companies with published settlements

Share this collection — free to repost with a link back.

There may be money with your name on it.

Free to browse and track. Every record shows its official-evidence status — and you open the official claim form yourself.

Check what you may be owed Browse all settlements